Company / Current Assets per Share
Protagonist Therapeutics, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$9.09
FY2025
5-year range
$4.96 / $9.09
FY2021-FY2025
Trend
-0.1%
vs FY2024
Sector context
#82 of 210
Health Care
What the data says
At $9.09, Protagonist Therapeutics, Inc.'s current assets per share ranks #82 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 10 years, ranging from $4.96 in FY2022 to $12.80 in FY2016.
Based on SEC 10-K filings.
9.09 in FY2025 with a 5-year CAGR of -0.2%.
Improved from $6.26 to $9.09 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +22.4%
- 5-Year CAGR
- -0.2%
- 10-Year CAGR
- -
Sector benchmark
#82 of 210 in Health CareTop 39% of 210This company $9.09 Sector average $170.65
▼
-94.7% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 0.1% year-over-year.
- Ranks #82 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2016.
- Lowest current assets per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.09 | -0.1% |
| FY2024 | $9.09 | +45.1% |
| FY2023 | $6.26 | +26.4% |
| FY2022 | $4.96 | -32.6% |
| FY2021 | $7.36 | -19.8% |
| FY2020 | $9.18 | +63.5% |
| FY2019 | $5.61 | -8.7% |
| FY2018 | $6.15 | -27.9% |
| FY2017 | $8.53 | -33.4% |
| FY2016 | $12.80 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026